Kubota Y - Search Results

1

Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development.

Ishiguro H, Nakaigawa N, Miyoshi Y, Fujinami K, Kubota Y, Uemura H. Ishiguro H, et al. Among authors: kubota y. Prostate. 2005 Jun 15;64(1):92-100. doi: 10.1002/pros.20219. Prostate. 2005. PMID: 15666359

2

55 kDa nuclear matrix protein (nmt55) mRNA is expressed in human prostate cancer tissue and is associated with the androgen receptor.

Ishiguro H, Uemura H, Fujinami K, Ikeda N, Ohta S, Kubota Y. Ishiguro H, et al. Among authors: kubota y. Int J Cancer. 2003 May 20;105(1):26-32. doi: 10.1002/ijc.11021. Int J Cancer. 2003. PMID: 12672026

3

Expression of AR associated protein 55 (ARA55) and androgen receptor in prostate cancer.

Miyoshi Y, Ishiguro H, Uemura H, Fujinami K, Miyamoto H, Miyoshi Y, Kitamura H, Kubota Y. Miyoshi Y, et al. Among authors: kubota y. Prostate. 2003 Sep 1;56(4):280-6. doi: 10.1002/pros.10262. Prostate. 2003. PMID: 12858356

4

Angiotensin II receptor blocker shows antiproliferative activity in prostate cancer cells: a possibility of tyrosine kinase inhibitor of growth factor.

Uemura H, Ishiguro H, Nakaigawa N, Nagashima Y, Miyoshi Y, Fujinami K, Sakaguchi A, Kubota Y. Uemura H, et al. Among authors: kubota y. Mol Cancer Ther. 2003 Nov;2(11):1139-47. Mol Cancer Ther. 2003. PMID: 14617787

5

Genistein induces cell growth inhibition in prostate cancer through the suppression of telomerase activity.

Ouchi H, Ishiguro H, Ikeda N, Hori M, Kubota Y, Uemura H. Ouchi H, et al. Among authors: kubota y. Int J Urol. 2005 Jan;12(1):73-80. doi: 10.1111/j.1442-2042.2004.00973.x. Int J Urol. 2005. PMID: 15661057

6

Neuroserpin (PI-12) is upregulated in high-grade prostate cancer and is associated with survival.

Hasumi H, Ishiguro H, Nakamura M, Sugiura S, Osada Y, Miyoshi Y, Fujinami K, Yao M, Hamada K, Yamada-Okabe H, Kubota Y, Uemura H. Hasumi H, et al. Among authors: kubota y. Int J Cancer. 2005 Jul 20;115(6):911-6. doi: 10.1002/ijc.20967. Int J Cancer. 2005. PMID: 15723353

7

Antiproliferative efficacy of angiotensin II receptor blockers in prostate cancer.

Uemura H, Nakaigawa N, Ishiguro H, Kubota Y. Uemura H, et al. Among authors: kubota y. Curr Cancer Drug Targets. 2005 Aug;5(5):307-23. doi: 10.2174/1568009054629663. Curr Cancer Drug Targets. 2005. PMID: 16101380 Review.

8

Antiproliferative activity of angiotensin II receptor blocker through cross-talk between stromal and epithelial prostate cancer cells.

Uemura H, Ishiguro H, Nagashima Y, Sasaki T, Nakaigawa N, Hasumi H, Kato S, Kubota Y. Uemura H, et al. Among authors: kubota y. Mol Cancer Ther. 2005 Nov;4(11):1699-709. doi: 10.1158/1535-7163.MCT-04-0295. Mol Cancer Ther. 2005. PMID: 16275991

9

Pilot study of angiotensin II receptor blocker in advanced hormone-refractory prostate cancer.

Uemura H, Hasumi H, Kawahara T, Sugiura S, Miyoshi Y, Nakaigawa N, Teranishi J, Noguchi K, Ishiguro H, Kubota Y. Uemura H, et al. Among authors: kubota y. Int J Clin Oncol. 2005 Dec;10(6):405-10. doi: 10.1007/s10147-005-0520-y. Int J Clin Oncol. 2005. PMID: 16369744 Clinical Trial.

10

Renin-angiotensin system is an important factor in hormone refractory prostate cancer.

Uemura H, Hasumi H, Ishiguro H, Teranishi J, Miyoshi Y, Kubota Y. Uemura H, et al. Among authors: kubota y. Prostate. 2006 Jun 1;66(8):822-30. doi: 10.1002/pros.20407. Prostate. 2006. PMID: 16482568

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,071 results

Search Page

Filters